Susan Nabadda Ndidde
ID: UNCST-2020-R014331
|
CD4 Testcard Digital Reader Study for VISITECT® CD4 Advanced Disease Testing in Uganda
REFNo: HS7194ES
Evaluate improvements in kit traceability, including visibility of lot numbers, expiry dates, and test-kit linkage to results.,Assess improvements in test-level traceability, including visibility of test counts, site locations, and test operators, comparing pre- and post-CD4R implementation.,Evaluate changes in user competency requirements and training processes, based on process mapping before and after implementation of the CD4R.,Assess whether the implementation of the CD4R improves standardization of test results by reducing error in test administration and interpretation. ,Assess staff-reported usability and workflow burden associated with the CD4 test, comparing pre- and post-CD4R implementation.,To assess the impact of digitalization on the result interpretation of the VISITECT® CD4 Advanced Disease test using the TestCard CD4 Digital Reader in Uganda,
|
Uganda |
2026-03-24 8:50:52 |
2029-03-24 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Racheal Angom
ID: UNCST-2023-R007485
|
Appropriateness, Acceptability, Feasibility, and Usability of an Electronic Medical Records System for Improving Diagnostic Processes and Multidisciplinary Care for Children and Adolescents with Cancer in Uganda: An Implementation Science Approach.
REFNo: HS7249ES
1.Identify barriers and facilitators to EAFYA implementation.
2.Co-design, test, refine, and implement EAFYA-supported diagnostic and MDT pathways.
3.Evaluate implementation success by assessing usability, appropriateness, acceptability, and feasibility.
|
Uganda |
2026-03-19 16:19:07 |
2029-03-19 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Dennis Muhanguzi
ID: UNCST-2019-R001101
|
Evaluation of The Safety, Efficacy and Stability of SangaDelta® Emulsifiable Concentrate [E.C]: A Randomised Single-Blinded Positive Controlled Multi-Site Acaricide Field Trial
REFNo: NS1194ES
General objectives
To determine the efficacy, safety, and stability of SangaDelta® (Sanga Vet. Chem. Ltd, Kampala Industrial Park, Namanve ) when applied onto cattle by hand spraying and plunge dipping for tick control.
Specific objectives
The specific objectives of this acaricide field trial will to determine:
i.Efficacy of SangaDelta® when applied onto cattle by hand spraying and plunge dipping for tick control.
ii.Safety of SangaDelta® when applied onto cattle by hand spraying and plunge dipping for tick control.
iii.Stability of SangaDelta® when applied onto cattle by plunge dipping for tick control.
|
Uganda |
2026-03-19 16:13:37 |
2029-03-19 |
Natural Sciences |
Clinical Trial |
Non-degree Award |
|
Jane Frances ABODO
ID: UNCST-2026-R023717
|
The 48-Hour Rule on Arraignment of Suspects in Uganda: An Analysis Under International Human Rights Law
REFNo: SS5047ES
(i) To analyze the key differences and similarities between arrest in the laws of Uganda and International Human rights law.
(ii) To analyze key differences and similarities between legal representation in the laws of Uganda and international human rights law.
(ii) To analyze the key differences between the nature of crime in the laws of Uganda and international human rights law.
(iv) To analyze the factors that affect the alignment of the 48-hour rule in the laws of Uganda to international human rights law.
|
Uganda |
2026-03-19 16:09:10 |
2029-03-19 |
Social Science and Humanities |
Non-Clinical Trial |
Degree Award |
|
Daniel Mwandah Chans
ID: UNCST-2022-R008880
|
DEVELOPMENT AND OPTIMIZATION OF ANTIBIOTIC TREATMENT ALGORTHM FOR THE ICU AMID ANTIBIOTIC RESISTANCE: INSIGHTS FROM MBARARA REGIONAL REFERRAL HOSPITAL
REFNo: HS7191ES
4. To develop and validate an antimicrobial optimization tool using biomarkers and antimicrobial Susceptibility data,3. To determine key resistance genes in MDROs from isolates collected among ICU patients in South Western Uganda using PCR.,2. To determine the prevalence, associated factors and patient outcomes among ICU patients with MDROs at ICU of MRRH,1. To conduct a systematic literature review on prevalence, factors associated with, mortality rate, patient outcomes and mechanisms of resistance of MDROs in ICUs in Sub Saharan Africa,The main aim of this proposal is to study MDROs in the ICU of MRRH and optimizing antimicrobial therapy to improve patient outcomes by determining utilization of biomarkers (PCT and CRP) and antibiotic susceptibility tests (ASTs).,
|
Uganda |
2026-03-19 16:07:23 |
2029-03-19 |
Medical and Health Sciences |
Non-Clinical Trial |
Degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|